TY  - GEN
AU  - Ashina,Messoud
AU  - Dodick,David
AU  - Goadsby,Peter J
AU  - Reuter,Uwe
AU  - Silberstein,Stephen
AU  - Zhang,Feng
AU  - Gage,Julia R
AU  - Cheng,Sunfa
AU  - Mikol,Daniel D
AU  - Lenz,Robert A
TI  - Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study
SN  - 1526-632X
PY  - 2017///1004
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Calcitonin Gene-Related Peptide Receptor Antagonists
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Migraine Disorders
KW  - prevention & control
KW  - Outcome Assessment, Health Care
KW  - Patient Reported Outcome Measures
N1  - Publication Type: Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article
UR  - https://doi.org/10.1212/WNL.0000000000004391
ER  -